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Abstract
Background: It has been previously shown that cultured granulosa cells (GCs) derived from human ovarian
preovulatory follicles contain choline acetyltransferase (ChAT), the enzyme responsible for acetylcholine (ACh)
synthesis. They also produce ACh and express functional muscarinic ACh receptors. ACh can act on GCs to
increase proliferation, disrupt gap junctional communication, alter intracellular calcium levels, as well as
expression of transcription factors, suggesting an unrecognized role of ACh in GC function. To gain further
insights into the possible role of ACh in the ovary, we examined ChAT expression in the gland before and after
birth, as well as in adults, and studied the regulation of ACh production by FSH.
Methods: ChAT immunohistochemistry was performed using ovarian samples of different species and ages
(embryonic, postnatal and adult rats and mice, including embryonic ovaries from mice null for ChAT, neonatal
and adult rhesus monkeys and adult humans). ACh was measured by HPLC and/or a fluorescence based method
in rat ovaries and in a FSH receptor-expressing cell line (rat GFSHR-17) cultured with or without FSH.
Results: In adult rat, as well as in all other species, ovarian ChAT immunoreactivity is associated with GCs of
antral follicles, but not with other structures, indicating that GCs are the only ovarian source of ACh. Indeed ACh
was clearly detected in adult rat ovaries by two methods. ChAT immunoreactivity is absent from embryonic and/
or neonatal ovaries (mouse/rat and monkey) and ovarian development in embryonic mice null for ChAT appears
normal, suggesting that ACh is not involved in ovarian or follicular formation. Since ChAT immunoreactivity is
present in GCs of large follicles and since the degree of the ChAT immunoreactivity increases as antral follicles
grow, we tested whether ACh production is stimulated by FSH. Rat GFSHR-17 cells that stably express the FSH
receptor, respond to FSH with an increase in ACh production.
Conclusion: ACh and ChAT are present in GCs of growing follicles and FSH, the major driving force of follicular
growth, stimulates ACh production. Since ACh stimulates proliferation and differentiation processes in cultured
GCs, we suggest that ACh may act in the growing ovarian follicle as a local mediator of some of the actions
ascribed to FSH.
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Introduction
Several publications have challenged the concept that ace-
tycholine (ACh) in the ovary derives from a cholinergic
innervation of the gland [see [1-5]]. Instead, ACh is pro-
duced by non-neuronal cells of the ovary, and specifically
by granulosa cells (GCs). HPLC measurements provided
unequivocal evidence for ACh production by human GCs
derived from large preovulatory follicles of women under-
going in vitro fertilization, and for ACh production in a
rat cell line (GFSHR-17) [6], derived from an antral rat fol-
licle (see summary in [1]).
Furthermore, ChAT protein was detected in GCs of large
antral follicles by immunohistochemisty [3,7-9]. These
morphological observations, together with a host of data
showing actions of cholinergic agents on cultured human
GCs [7-11] provide evidence for the concept that ACh is
produced locally in the ovary, and acts within the gland to
affect specific ovarian functions (see also [1-3]). Thus,
human GCs contain muscarinic ACh receptors (MR) and
ACh regulates cell proliferation via MR, inhibits gap-juc-
tional communication, and among other actions, stimu-
lates the transcription factor egr-1 (early growth response
factor 1) [9]. MR of human GCs are G-protein coupled
receptors linked to increases in intracellular calcium lev-
els. They are also linked to activation of calcium activated
potassium channels (BKCa [11]). Data from this study also
indicate that activated BKCa channels are necessary for
hCG to exert its stimulatory action on steroid production
[11]. It is thus possible that an intraovarian ACh/MR sig-
naling complex may be complementary to the cAMP/PKA
signaling pathway used by gonadotrophins in GCs
[12,13]. Relevant to this issue is the demonstration that
oocytes possess functional MRs and represent, therefore,
also a target for ACh [8,14,15].
Whether ACh production is restricted to preovulatory fol-
licles and how the production of ACh by antral follicles is
regulated, remain unknown [16]. We have, therefore,
examined the ovarian sites of ChAT expression in rodents
and primates and have determined whether ovarian mor-
phology is altered in ChAT knockout mice. We also meas-
ured ACh levels in adult ovaries and tested the possibility
that FSH, the hormone required for antral follicular
growth, may affect ACh production by GCs.
Methods
Tissues
Paraffin-embedded, fixed human ovaries (n = 3) were
from patients undergoing gynecological surgery. The pro-
cedures were approved by the local Ethics Committees
and patients gave written consent to the use of tissues.
Additional samples (n = 4) were from a tissue bank, as
described [17]. Sections (10 μm) were cut and used for
immunohistochemistry.
Monkey ovarian samples (obtained at necropsy or during
surgery for unrelated reasons at the ONPRC-OHSU) were
from postnatal day 0, 1, and 3–17 years of age, total of 10
samples). The care and housing of rhesus macaces
(Macaca mulatta) at the ONPRC was previously described
[11,17]. Animal protocols and experiments were
approved by the ONPRC Animal Care and Use Commit-
tee, and studies were conducted in accordance with the
NIH Guide for the Care and Use of Laboratory Animals.
Sections (10 μm) were cut from all paraffin-embedded
samples and were used for immunohistochemistry.
Mouse and rat ovarian samples used (from embryonic
stages, i.e. post coitus (p.c.) 17, 18, 20, postnatal day 0,
day 1 and adult) were derived from previous studies
[7,18-20].
ChAT knockout (-/-) mice were generously provided by
Fred Gage and Kuo-Fen Lee [21]. Mice were genotyped as
described [21] using primers ATGATGACAGGCAACAA-
GAAGC, CTTCCATTTGTCACGTCCTGC and AGGGAT-
GAGAATGGGTGGAGCC, which resulted in PCR products
of 240 bp for the wildtype gene and 364 bp for the knock-
out gene, respectively. Heterozygous males and females
were mated and the day of conception was determined by
presence of a vaginal plug or sperm in the vagina. Fetuses
were obtained by caesarian section on day 18 p.c. and ova-
ries dissected out. Fetuses were genotyped from tail DNA
and ovaries from ChAT (-/-) and wildtype control mice (+/
+) were fixed in Bouin's and embedded in paraffin. Sec-
tions (10 μm) of 5 ovaries of each group were made and
were stained with H.E.
Immunohistochemistry and immunofluorescence
The ABC method and DAB as a chromogen were used for
immunohistochemistry, while FITC-labeled secondary
antiserum was used for immunofluorescence. All proce-
dures were performed as described [9,11,20,22]. A specific
mouse anti ChAT monoclonal antibody (1:500 to
1:1,000; Boehringer Mannheim, Mannheim, Germany)
was used. For controls, incubation with mouse normal
serum, IgG or buffer without the specific antibody was
employed, as described. Incubations with the primary
antibody were carried out overnight at 4°C, incubations
with the secondary antiserum were done at room temper-
ature for 2 h.
ACh measurement in rat ovaries
We studied whether ACh is present in adult rat ovaries. To
this end ovaries from 11 adult rats, used in unrelated
experiments, were examined. Animals were kept at the
animal house of the Technical University of Munich and
killed according to NIH/local animal care guidelines.Reproductive Biology and Endocrinology 2006, 4:37 http://www.rbej.com/content/4/1/37
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Ovaries were rapidly removed, frozen on liquid nitrogen
and ACh was either determined using the HPLC method,
as described previously (n = 6 adults; see [7,8]) or a fluo-
rescence-based method (5 adults). To perform the latter,
each ovary was homogenized in 500 μl cold 10 mM PBS
on ice and samples were either stored at -80°C until use
or were used immediately. Before measurement they were
centrifuged and the supernatant was subjected to ACh
detection using the Amplex Red Acetylcholine Assay kit
(Molecular Probes/Invitrogen GmbH, Karlsruhe, Ger-
many).
Briefly, in this assay ACh is hydrolyzed by ACh esterase
(AChE), the choline formed is then oxidized by choline
oxidase, and the H2O2 resulting from this reaction, inter-
acts with Amplex Red (7-dihydroxyphenoxazine) in the
presence of horseradish peroxidase to form the highly flu-
orescent resorufin. The samples were transferred into a 96-
well plate and measured in a fluorescence plate reader
(BMG Labtech GmbH, Offenburg, Germany) every 5 min
for 40 min. All measurements were performed in tripli-
cates. As this assay detects not only ACh, but also choline,
we measured each sample in the absence of AChE, as well.
Sensitivity of the assay was as low as 0.3 μM, with a range
of detection from 0.3 μM to 100 μM ACh. For quantifica-
tion purposes, ACh solutions in the range of 0 μM to 3 μM
were measured, and a calibration curve was generated
from the values obtained. The ratio of fluorescence inten-
sities obtained in the presence of AChE divided by those
in its absence was 1.2 ± 0.1 (n = 5 ovaries from 5 animals;
mean ± SD; one-sample t-test, P = 0.0014). A value larger
than one indicates that ACh was present in the samples.
The choline detected by the assay can derive from endog-
enous sources and/or originate from non-enzymatic
hydrolysis of ACh and/or from enzymatic hydrolysis of
ACh by intrinsic esterase activity of the tissue. Thus, to
semi-quantitatively assess ACh concentrations we sub-
tracted the choline values obtained in absence of AChE
from those in its presence.
Culture of GFSHR-17 cells for ACh determination
GFSHR-17 cells are derived from antral rat follicles, but
are not able to produce estrogens [23]. Yet, they respond
to FSH [6,23]. All methods, including description of cul-
ture conditions have been reported in detail [23]. In brief,
cells were cultured with Dulbecco modified Eagle
medium Ham's F12 (1:1 (v/v); Biochrom KG, Berlin, Ger-
many) containing 5% fetal calf serum (Biochrom KG, Ber-
lin, Germany). Cells were maintained in culture for up to
25 passages and were treated as indicated with/without
porcine (p) FSH (0.5 IU/ml; Sigma, Deissenhofen, Ger-
many) for 24 h and with lower concentrations for pilot
studies. As reported previously, pFSH only slightly stimu-
lates progesterone production by GFSHR-17 cells [23].
Cellular content of ACh was determined (8 samples/
group from 3 independent experiments) as described pre-
viously [7,8,16] and was normalized to cellular protein.
Results are expressed as means ± SEM. Statistical signifi-
cance of changes was determined using t-test.
Results
ChAT immunoreactivity in the ovary
ChAT immunoreactivity, as expected, was observed in
human, monkey and rat adult ovaries only in GCs of large
antral follicles, but not in small follicles (see Fig. 1 and 2).
Immunoreactive nerve fibers, expected to be present in
interstitial or thecal areas and around blood vessels, were
not observed. ChAT was absent from neonatal or postna-
tal (day 0 and 6) rat ovary (Fig. 2). Likewise, neonatal (day
1) monkey ovaries were devoid of ChAT immunoreactiv-
ChAT in adult primate ovaries Figure 1
ChAT in adult primate ovaries. A: ChAT is detectable 
using immunohistochemical methods in a monkey ovary only 
in the GC layer (arrows) of several large antral follicles. Note 
that the areas between the sectioned follicles are devoid of 
any immunoreactive structures. Bar = 500 μm. B: A consecu-
tive section of the one shown in A is depicted and used as a 
control (incubation with non-immune mouse normal serum 
instead of the specific antibody). The asterisk denotes a large 
antral follicle. Bar = 200 μm. C. Immunoreactive GCs of a 
large antral follicle in a human ovary. Bar = 50 μm.Reproductive Biology and Endocrinology 2006, 4:37 http://www.rbej.com/content/4/1/37
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ity, as were rat and mouse embryonic (p.c. 18) ovaries
(Fig. 2, 3; rat not shown).
Furthermore ovarian development in embryonic mutant
mice null for ChAT was normal with respect to organ size
and cellular composition, ruling out an involvement of
ACh in the early ovarian development (Fig. 3).
Ovarian ACh levels
Expression of ChAT in adult rat ovaries is associated with
the presence of ACh (n = 6); the mean value was 2.47 ±
0.90 pmol (mean ± SEM) as detected by a HPLC tech-
nique. The presence of ACh in rat ovaries was corrobo-
rated using a fluorescence technique (n = 5), and the
values obtained ranged between 22 and 60 pmol (mean ±
SEM: 43 ± 7 pmol).
Regulation of ACh production by FSH in a rat GC line
Since follicular growth and GC development depend on
FSH, we hypothesized that ACh production may be stim-
ulated by the gonadotrophin. To test this possibility we
determined the production of ACh in the rat GFSHR-17
cell line challenged with pFSH for 24 h. This cell line sta-
bly expresses the FSH receptor and is immunoreactive for
ChAT (Fig. 4). Using a HPLC detection system, we found
a statistically signifcant increase in ACh production (p <
0.05; Fig. 4C).
Discussion
The present results demonstrate (1) the presence of ACh
in adult rat ovary and (2) indicate that GCs of growing
ChAT is present in growing antral follicles of rat and monkey  ovary Figure 2
ChAT is present in growing antral follicles of rat and 
monkey ovary. A-C: Rat ovaries: ChAT is not detectable 
using immunohistochemical methods in a rat ovary at postna-
tal days 0 or 6 (A, B). Bars = 50 μm. In adult rat ChAT (C) is 
present in GCs of antral follicles. Bar = 100 μm. D-F: Monkey 
ovaries: ChAT is not detectable using immunohistochemical 
methods in a monkey ovary at postnatal day 1 (D). The same 
ovary is shown after staining with H.E. to reveal structural 
details of follicle formation (E). Bars = 50 μm. F: Immunohis-
tochemistry of an adult monkey ovary showing a large antral 
follicle (two asterisks) strongly stained for ChAT, preantral 
follicles (arrows) devoid of staining, and the appearance of 
immunoreactivity in follicles with incipient antrum formation 
(asterisk). Bar = 100 μm.
Absence of ChAT in embryonic mouse ovary and morphol- ogy of ChAT (-/-) mouse ovary Figure 3
Absence of ChAT in embryonic mouse ovary and 
morphology of ChAT (-/-) mouse ovary. A: ChAT is not 
detectable using immunohistochemical methods in a mouse 
ovary at day 18 p.c. Bar = 50 μm. B-C: H.E. stained sections 
of the ovary of an embryonic (day 18 p.c.) age-matched wild-
type ovary (+/+) and a mutant mouse null for ChAT (-/-). 
Bars = 60 μm.Reproductive Biology and Endocrinology 2006, 4:37 http://www.rbej.com/content/4/1/37
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antral ovarian follicles in both rodents and primates are
the only detectable structures, which are immunoreactive
for ChAT, implying that GCs are the source of ovarian
ACh. Furthermore (3) our results indicate that ChAT
staining increases in GCs of growing antral ovarian folli-
cles in both rodents and primates and (4) show that FSH
stimulates production of ACh in cells derived from an
antral follicle. Finally, (5) since ChAT is absent from
embryonic and neonatal ovary and embryonic develop-
ment in ChAT-/- mice appears normal, these data support
the hypothesis that ACh is a signaling molecule important
for the antral follicle, which is produced by non neuronal
cells of the ovary under gonadotrophin control.
A role of ACh in the ovary has only recently been sug-
gested, based on studies with human GCs [1]. These cells,
derived from the preovulatory follicle of women undergo-
ing in vitro fertilization procedures, bear resemblance to
preovulatory follicular GCs. In the present study we
sought to further define this ovarian site of presumed ACh
synthesis.
We confirmed that in rodents and primates only growing
follicles express ChAT, and thus, are likely to produce
ACh. The ChAT protein is not found in embryonic and
neonatal ovary and is first detected in follicles that are
beginning to develop an antrum, i.e. a stage supported by
FSH, which drives subsequent follicular growth
[12,13,24]. Since preantral follicles lack ChAT, ACh may
not be important for events taking place before antrum
formation, including the embryonic phase of ovarian
development. Unfortunately, ChAT null mice die at birth
[21] precluding examination of postnatal ovarian devel-
opment.
The increased ChAT immunoreactive signal detected in
larger antral follicles, as compared with smaller antral fol-
licles, suggested that ACh production may be regulated by
FSH. This conclusion is supported by the results of our
studies with immortalized GCs, which stably express
functional FSH receptors [23], as these cells responded to
FSH with increased production of ACh. This increase
likely reflects an enhanced production of ACh per cell,
because GFSHR-17 cells do not proliferate when treated
with FSH [23], and the ACh values were expressed in rela-
tion to cellular protein content. A potential involvement
of estrogens in ACh production can be ruled out (see
[23]). Although estrogens are also produced by GCs of
growing follicles in response to FSH, GFSHR-17 cells do
not produce estrogens when challenged with FSH (see
[23] for details). These cells however produce small
amounts of progesterone [23]. The cellular mechanisms
employed by FSH to increase ACh production remain to
be elucidated.
We clearly detected ACh itself by two techniques in
homogenates from adult rat ovaries, in which ChAT
immunoreactive GCs are present. Preliminary unpub-
lished studies with immature rat ovarian homogenates
(from ovaries of days 1–6) have sofar indicated that ACh
in these samples is below detection limits. These results
are consistent with the observed and documented lack of
ChAT in the neonatal ovary (present study). More detailed
studies, which are beyond the present report, are however
required to examine ovarian ACh levels during sexual
maturation and correlate them with ovarian and follicular
development.
When measuring ovarian ACh content in adults we did
not differentiate between ovaries bearing differently sized
follicles or corpora lutea and the results obtained reflect a
thus expected heterogeneity. Furthermore the two differ-
ent methods employed provided somewhat different
Regulation of ACh production in GCs by FSH Figure 4
Regulation of ACh production in GCs by FSH. A: 
Immunostaining of ChAT in GFSHR-17 cells and B: lack of 
staining in control cells incubated with mouse serum instead 
of the specific antibody. Bar = 10 μm. C: Rat GFSHR-17 cells 
incubated for 24 h with 0.5 mIU/ml of porcine FSH respond 
with a significant increase in ACh production. Results shown 
represent means and SEM of 8 samples per group. Results of 
untreated cells were set to 1 (t-test; p < 0.05).Reproductive Biology and Endocrinology 2006, 4:37 http://www.rbej.com/content/4/1/37
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absolute values. Several reasons may account for these dif-
ferences, which have to do with the principles of the
assays used (HPLC detection versus enzymatic assay). Fur-
thermore, it is possible that the magnitude of the changes
is, at least in part, determined by changes in ACh metabo-
lism. ACh is a very labile molecule with a very short half
life time. Our preliminary data from fluorescence ACh
assays strongly suggests presence of esterases degrading
ACh, and preliminary Western blot data implicates
butyrylcholine esterase [25,26] as one of the esterases
involved. Clearly, additional studies are required to eluci-
date the mechanisms of inactivation of ACh by GCs in the
ovary.
ACh has only recently been recognized as a "cyto-trans-
mitter" that, produced by non-neuronal cells, can act
throughout the body in an autocrine and/or paracrine
fashion (see [27]). It is now known that a variety of cells,
including epithelial cells, endothelial cells, cancer cells,
immune cells and placental tissue produce ACh and pos-
sess ACh receptors [16,28,29]. Importantly, ChAT activity
of human placental cells is not affected by LH or FSH [28],
suggesting that an FSH-dependent regulation in GCs is a
cell-specific event.
Conclusion
ACh and ChAT are present in GCs of growing follicles and
the hormone FSH, the major driving force of follicular
growth, stimulates ACh production. Since ACh stimulates
proliferation and differentiation processes in cultured
GCs (see summary in [1-3]), we suggest that ACh may act
in the growing ovarian follicle as a local mediator of some
of the actions ascribed to FSH.
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